IGAM
CYTK icon

iA Global Asset Management’s Cytokinetics CYTK Stock Holding History

iA Global Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,540
Closed -$1.55M – 469
2023
Q3 		$1.55M Sell
52,540
-90
-0.2% -$3K 0.04% 242
2023
Q2 		$1.72M Buy
+52,630
New +$1.95M 0.05% 240

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

iA Global Asset Management's CYTK Position: Q4 2023 in Review

iA Global Asset Management sold out of Cytokinetics (CYTK) in Q4 2023, closing a stake of 52,540 shares — an estimated $1.55M sold.

iA Global Asset Management first reported a position in CYTK in Q2 2023 and held it in 2 quarters. The position peaked at $1.72M in Q2 2023. 347 funds tracked by Wall St. Rank hold CYTK as of Q4 2023.

  • iA Global Asset Management reported no remaining Cytokinetics position as of Q4 2023 after selling out during the quarter.
  • iA Global Asset Management sold 52,540 Cytokinetics shares in Q4 2023, an estimated $1.55M.
  • iA Global Asset Management first reported a position in Cytokinetics in Q2 2023 and held it in 2 quarters.
  • iA Global Asset Management's Cytokinetics position peaked at $1.72M in Q2 2023.
  • 347 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2023.

Based on iA Global Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.